The COVID Impact
Top life science experts share successful quality, compliance, and risk mitigation strategies during COVID and going forward.
You’ll walk away with a brand new “COVID playbook” consisting of insights and recommendations you can use immediately.
This was a live webinar, now you get the chance to see the recording
We are sharing everything we learned about leading quality and compliance to meet and exceed goals during COVID-19
You'll gain insights and recommendations on the best strategies, tools and capabilities you need to maintain compliance, to achieve growth, and to meet goals.
Get the most interesting insights from Quality, GxP and Compliance leaders on how to lead in this time of crisis.
Because business must go on...
Vice President Head of Quality at Axcella Health
Responsible for executing the quality vision and leading all GXP Quality activities and operations.
Amnon has played a lead role working with regulators on a global scale with leading organizations such as Amgen, Lilly, Sanofi and successful startups such as Karyopharm.
Like everyone else, we’ve pivoted our strategies, and tactics to adjust to COVID and maintain safety.
You’re not alone. Join us to get the best prescriptive on tactics you need to pivot your quality and compliance strategies in order to continue growing during this period of disruption.
VP Sales and Business Development at Dot Compliance
Mickey has over 13 years of Quality Management Systems expertise working with some of the most innovative technologies available for highly regulated industries.
He has worked on numerous quality and compliance initiatives with some of the largest life science organizations as well as many emerging startups.
FDA/EU Compliance Consultant and medical device specialist
With over 25 years of experience in medical devices, Andre is an expert in the areas of product development, quality and regulatory submissions of 510(k), PMA and CE marked medical devices.
Andre has been a consultant to well over 30 companies’ including fortune 100 companies such as Medtronic and a predominance of startups.